World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
61
Citations
12347
World Ranking
11431
National Ranking
4938

Overview

Michael D. Cameron is affiliated with the Scripps Research Institute in the United States. Their research spans across multiple fields, primarily in Biochemistry, Genetics and Molecular Biology, with a total of 76 publications, and Medicine, comprising 64 publications.

Their work delves into several subfields including Molecular Biology, Cellular and Molecular Neuroscience, Oncology, Infectious Diseases, and Genetics. The scientist's research also concentrates on topics such as Receptor Mechanisms and Signaling, Neuropeptides and Animal Physiology, Pharmacological Receptor Mechanisms and Effects, RNA Interference and Gene Delivery, RNA Research and Splicing, Histone Deacetylase Inhibitors Research, and Viral Infections and Vectors.

Michael D. Cameron has published papers in various venues. The most frequent ones include bioRxiv (Cold Spring Harbor Laboratory) with 9 publications, Journal of Medicinal Chemistry with 6 publications, UNC Libraries with 5 publications, Journal of the American Chemical Society and Blood, each with 4 publications.

Recent notable papers published by the scientist include:

  • An allosteric inhibitor against the therapy-resistant mutant forms of EGFR in non-small cell lung cancer, 2022, Nature Cancer
  • Structure-based design of bitopic ligands for the µ-opioid receptor, 2022, Nature
  • Increased lysosomal biomass is responsible for the resistance of triple-negative breast cancers to CDK4/6 inhibition, 2020, Science Advances
  • Reprogramming of Protein-Targeted Small-Molecule Medicines to RNA by Ribonuclease Recruitment, 2021, Journal of the American Chemical Society
  • Design of a small molecule that stimulates vascular endothelial growth factor A enabled by screening RNA fold-small molecule interactions, 2020, Nature Chemistry

The scientist collaborates regularly with several coauthors. Frequent collaborators include Theodore M. Kamenecka (12 joint publications), Claudia Ruiz (11), Gavin Rumbaugh (9), Patrick R. Griffin (9), and Courtney A. Miller (9).

Best Publications

  • Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists

    Laura A. Solt;Yongjun Wang;Subhashis Banerjee;Travis G Hughes

  • Antidiabetic actions of a non-agonist PPARγ ligand blocking Cdk5-mediated phosphorylation

    Jang Hyun Choi;Alexander S. Banks;Theodore M. Kamenecka;Scott A. Busby

  • A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response

    Zhao Chen;Katherine Cheng;Zandra Walton;Yuchuan Wang

  • Bias Factor and Therapeutic Window Correlate to Predict Safer Opioid Analgesics

    Cullen L. Schmid;Nicole M. Kennedy;Nicolette C. Ross;Kimberly M. Lovell

  • Blocking Lactate Export by Inhibiting the Myc Target MCT1 Disables Glycolysis and Glutathione Synthesis

    Joanne R. Doherty;Chunying Yang;Kristen E.N. Scott;Michael D. Cameron

  • Insular hypocretin transmission regulates nicotine reward

    Jonathan A. Hollander;Qun Lu;Michael D. Cameron;Theodore M. Kamenecka

  • Enzymology of Phanerochaete chrysosporium with respect to the degradation of recalcitrant compounds and xenobiotics.

    M. D. Cameron;S. Timofeevski;S. D. Aust

  • Single and Dual Targeting of Mutant EGFR with an Allosteric Inhibitor.

    Ciric To;Jaebong Jang;Ting Chen;Eunyoung Park

  • An analog of the natural steroidal alkaloid Cortistatin A potently suppresses Tat dependent HIV transcription

    Guillaume Mousseau;Mark A. Clementz;Wendy N. Bakeman;Nisha Nagarsheth

  • Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria

    Tarsis F. Brust;Jenny Morgenweck;Susy A. Kim;Jamie H. Rose

  • Pharmacological inhibition of BMK1 suppresses tumor growth through promyelocytic leukemia protein.

    Qingkai Yang;Xianming Deng;Bingwen Lu;Michael Cameron

  • Biodegradation of superabsorbent polymers in soil

    James D. Stahl;Michael D. Cameron;Joachim Haselbach;Steven D. Aust

  • Design of a small molecule against an oncogenic noncoding RNA

    Sai Pradeep Velagapudi;Michael D. Cameron;Christopher L. Haga;Laura H. Rosenberg

  • Precise small-molecule recognition of a toxic CUG RNA repeat expansion

    Suzanne G Rzuczek;Lesley A Colgan;Yoshio Nakai;Michael D Cameron

  • Characterization of Dasatinib and Its Structural Analogs as CYP3A4 Mechanism-Based Inactivators and the Proposed Bioactivation Pathways

    Xiaohai Li;Yuanjun He;Claudia H. Ruiz;Marcel Koenig

  • Identification of SR1078, a synthetic agonist for the orphan nuclear receptors RORα and RORγ.

    Yongjun Wang;Naresh Kumar;Philippe Nuhant;Michael D. Cameron

  • Development of Functionally Selective, Small Molecule Agonists at Kappa Opioid Receptors

    Lei Zhou;Kimberly M. Lovell;Kevin J. Frankowski;Stephen R. Slauson

  • Amygdala-Dependent Fear Is Regulated by Oprl1 in Mice and Humans with PTSD

    Rauel Andero;Tanja Jovanovic;Yen T. Chen

  • Cellobiose dehydrogenase–an extracellular fungal flavocytochrome

    Michael D. Cameron;Steven D. Aust

  • Full Pharmacological Efficacy of a Novel S1P1 Agonist That Does Not Require S1P-Like Headgroup Interactions

    Pedro J. Gonzalez-Cabrera;Euijung Jo;M. Germana Sanna;Steven Brown

Frequent Co-Authors

William R. Roush
William R. Roush Scripps Research Institute
Patrick R. Griffin
Patrick R. Griffin Scripps Research Institute
Naresh Kumar
Naresh Kumar University of New South Wales
A. Donny Strosberg
A. Donny Strosberg Université Paris Cité
Thomas P. Burris
Thomas P. Burris Washington University in St. Louis
Gerald R. Smith
Gerald R. Smith Fred Hutchinson Cancer Research Center
Steven D. Aust
Steven D. Aust Utah State University
Hugh Rosen
Hugh Rosen Scripps Research Institute
Matthew D. Disney
Matthew D. Disney Scripps Research Institute
James H. McKerrow
James H. McKerrow University of California, San Diego

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re passionate about Biology or Biochemistry, your academic journey can lead to diverse career pathways in healthcare, research, fitness, and mental health. Today’s flexible learning environment also allows you to pursue advanced degrees online while balancing work and other commitments.

For those interested in clinical pharmacy, consider exploring online pharmd programs for non pharmacists—ideal for science graduates seeking to transition into pharmacy roles. If your interests lie in the science of movement, an online exercise physiology degree offers insights into human physiology, suitable for work in sports medicine and rehabilitation.

Similarly, a online kinesiology degree gives you the foundation to follow career paths in fitness training, wellness coaching, or physical therapy. Those looking to advance in mental health nursing might consider the shortest post master's pmhnp online programs, which offer a fast track to becoming a Psychiatric-Mental Health Nurse Practitioner.

Whether you’re aiming for direct patient care, research, or education, these online degree options are valuable stepping stones, making science-based professions more accessible than ever.

Best Scientists Citing Michael D. Cameron

Trending Scientists